ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Lipella Pharmaceuticals Inc

Lipella Pharmaceuticals Inc (LIPO)

0.3969
0.0027
( 0.68% )
업데이트: 23:40:48

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.3969
매수가
0.3951
매도가
0.397
거래량
89,678
0.39 일간 변동폭 0.397
0.3234 52주 범위 2.71
market_cap
전일 종가
0.3942
개장가
0.3942
최근 거래 시간
55
@
0.395201
마지막 거래 시간
23:43:59
재정 규모
US$ 35,332
VWAP
0.393985
평균 볼륨(3m)
3,907,250
발행 주식
8,004,636
배당수익률
-
주가수익률
-0.69
주당순이익(EPS)
-0.58
매출
450k
순이익
-4.62M

Lipella Pharmaceuticals Inc 정보

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic... Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Lipella Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker LIPO. The last closing price for Lipella Pharmaceuticals was US$0.39. Over the last year, Lipella Pharmaceuticals shares have traded in a share price range of US$ 0.3234 to US$ 2.71.

Lipella Pharmaceuticals currently has 8,004,636 shares in issue. The market capitalisation of Lipella Pharmaceuticals is US$3.16 million. Lipella Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.69.

LIPO 최신 뉴스

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc...

Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus

PITTSBURGH, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious...

Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York

PITTSBURGH, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouthNo FDA-approved therapy currently exists for OLPPatient registry and OLP study...

Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancerNovel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0849-17.62141967620.48180.50.392374080.45556489CS
40.00390.9923664122140.3930.540.3558703530.44708452CS
12-0.1112-21.8854556190.50811.50.323439072500.84614477CS
26-0.2771-41.11275964390.6741.50.323418373450.84347537CS
52-1.1931-75.03773584911.592.710.323411349011.05421839CS
156-6.6231-94.34615384627.027.720.32347778301.40023937CS
260-6.6231-94.34615384627.027.720.32347778301.40023937CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PEVPhoenix Motor Inc
US$ 0.7883
(126.85%)
63.78M
BENFBeneficient
US$ 1.9101
(60.51%)
84.7M
FORDForward Industries Inc
US$ 5.1299
(46.57%)
14.71M
SNALSnail Inc
US$ 1.01
(38.95%)
2.83M
NCNCnoco noco Inc
US$ 0.1754
(32.28%)
117.11M
ADDColor Star Technology Company Ltd
US$ 0.3222
(-28.40%)
5.47M
CETXCemtrex Inc
US$ 1.86
(-27.34%)
2.01M
LSBLakeShore Biopharma Company Ltd
US$ 5.0738
(-25.60%)
33.12k
TOIIWOncology Institute Inc
US$ 0.02
(-24.24%)
14.57k
UPXIUpexi Inc
US$ 2.5101
(-21.56%)
81.34k
NCNCnoco noco Inc
US$ 0.1754
(32.28%)
117.11M
NVDANVIDIA Corporation
US$ 123.4399
(0.48%)
89.65M
BENFBeneficient
US$ 1.914
(60.84%)
84.72M
SQQQProShares UltraPro Short QQQ
US$ 7.58
(-1.69%)
80.03M
PEVPhoenix Motor Inc
US$ 0.7875
(126.62%)
63.78M

LIPO Discussion

게시물 보기
glenn1919 glenn1919 1 주 전
LIPO............................https://stockcharts.com/h-sc/ui?s=LIPO&p=W&b=5&g=0&id=p86431144783
👍️0
TheFinalCD TheFinalCD 1 주 전
$LIPO Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) provided an update on its Phase 2a clinical trial for Oral Lichen Planus (OLP). The trial, evaluating the effectiveness of LP-310, an oral rinse, showed promising results with three participants completing the four-week treatment.…— PRISM MediaWire (@prism_mediawire) September 24, 2024
👍️0
tw0122 tw0122 1 주 전
Give me some liposuction and pump me up
👍️0
Monksdream Monksdream 1 월 전
LIPO new 52 low
👍️0
Monksdream Monksdream 2 월 전
LIPO new 52
👍️0
TheFinalCD TheFinalCD 2 월 전
agree but the market doesnt *NHOD*
👍️0
Swammmie1040 Swammmie1040 2 월 전
lol bounced out garbage geeezzzz
👍️0
Swammmie1040 Swammmie1040 2 월 전
Churning good bounce coming
👍️ 1
PirateLeviathan8 PirateLeviathan8 2 월 전
only initiates Phase 2a Trial
where is the big news ?

is just to collect money
👍️0
harry crumb harry crumb 2 월 전
Halted!, in at average .90, easily a 3$ stock here $$$$$$
👍️0
MartinLutherKing MartinLutherKing 2 월 전
God Bless LIPO God Bless RNAZ
👍️0
Awl416 Awl416 2 월 전
Ahhhhh chew. Bless me
👍️0
Awl416 Awl416 2 월 전
Don’t blink
👍️0
Awl416 Awl416 2 월 전
Golf clap
👍️0
glenn1919 glenn1919 2 월 전
LIPO...............................https://stockcharts.com/h-sc/ui?s=LIPO&p=W&b=5&g=0&id=p86431144783
👍️0
TheFinalCD TheFinalCD 2 월 전
LIPO NEWS https://www.globenewswire.com/news-release/2024/07/29/2920081/0/en/Lipella-Pharmaceuticals-Initiates-Phase-2a-Trial-for-LP-310-in-Oral-Lichen-Planus-Enrolls-First-Patients.html
👍️0
tw0122 tw0122 2 월 전
LIPO .80s now cash out time
👍️0
FALCON1 FALCON1 2 월 전
https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
👍️0
oldstocks oldstocks 7 월 전
You made me feel old, then i remembered my grandchildren
541,000 LIPO shares traded down 1.9%
Wow normally low volume
J A G X had a lot of volume too 380 mill
Pharmaceuticals are hot
👍️0
Muhbruh Muhbruh 7 월 전
$LIPO Bio with nice bottom chart 6.6m float, 10 months of cash Insiders own 36% Warrants at $1.40 last offering was at $1.52 and has Upcoming catalyst pic.twitter.com/2j5I3G9MTE— STOCKS Gambino (@StocksGambino) March 4, 2024
👍️0
Monksdream Monksdream 7 월 전
Roll the dice, gramps you can’t take it with you
👍️0
oldstocks oldstocks 7 월 전
This doesn’t trade many shares.
Volume is coming
👍️0
Monksdream Monksdream 7 월 전
LIPO under $2
👍️0
crudeoil24 crudeoil24 11 월 전
Heading to FDA phase II trial. Long ways to go before FDA phase III approval for marketplace.
👍️0
crudeoil24 crudeoil24 11 월 전
Shares of Lipella Pharmaceuticals Inc. (LIPO) rocketed 52.2% higher in very active tracing Friday, after the Pittsburgh-based biotechnology company's investigational new drug application for its oral lichen planus treatment was approved by the U.S. Food and Drug Administration. Trading volume in the stock, which was the best performer on the major U.S. exchanges, blasted higher to 30.7 million shares, compared with the full-day average of about 6,400 shares. The stock has soared 150% in the three days since it last closed below the $1 mark, and has run up 164% amid a six-day winning streak. as Lipella described, OLP is a chronic, inflammatory autoimmune oral muscosal disease. It is a "highly morbid" condition with malignant potential that affects between 1% and 4% of the world population. Lipella's stock has now gained 18.6% over the past three months, but was still 57% below its initial public offering price of $5.75; the company went public on Dec. 20.

-Tomi Kilgore

For more from MarketWatch: http://www.marketwatch.com/newsviewer
👍️0
Monksdream Monksdream 12 월 전
Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Awl416 Awl416 12 월 전
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus
👍️0
MiamiGent MiamiGent 2 년 전
That's it for me, folks!
Went much longer than usual but I have had a terrific day-following a bad day yesterday.
Hit on LIPO news today. Was positioned for the good pop. What a difference a day can make!
Have to drive across the mountain, now. Go do inventory at a shop open late. Then deliver there tomorrow.

LIPO Quote
AS OF 3/16/2023 3:16PM ET

$2.54
+$0.71 (+38.798%)

Volume
22,990,230
90 Day Avg. Vol.
564,085
Open
$2.77
Previous Close 03/15/2023
$1.83

https://stockcharts.com/h-sc/ui?s=LIPO
👍️0
TheFinalCD TheFinalCD 2 년 전
LIPO NEWS https://finance.yahoo.com/news/lipella-pharmaceuticals-successfully-completes-phase-123000776.html


Hemorrhagic cystitis is a medical condition that occurs when your urinary bladder lining becomes inflamed and bleeds. Your bladder is a muscular sac in your pelvis that stores urine before it's released from your body. Hemorrhagic means bleeding, and cystitis is inflammation of the bladder
👍️0
81vette 81vette 2 년 전
Lipella Pharmaceuticals’ (NASDAQ:LIPO – Get Rating) quiet period will expire on Monday, January 30th. Lipella Pharmaceuticals had issued 1,217,391 shares in its IPO on December 20th. The total size of the offering was $6,999,998 based on an initial share price of $5.75. During Lipella Pharmaceuticals’ quiet period, insiders and underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
👍️0
81vette 81vette 2 년 전
65,502 failure to deliver from 1-13 ,wow $300,000@$3.00pps ,insane margin call,shorts better cover now,at ask would put LIPO over $100pps right now ,set my sell at $150.00 just in case
👍️0
81vette 81vette 2 년 전
.05 spread,jumping .10-.50 today,no toxic debt or naked short on this newie,after market and pre-mkt tomorrow could gap LIPO multi$,gotta love low float newies
👍️0
81vette 81vette 2 년 전
35Xs ave vol,big pre mkt today 1st sign of life since ticker started,now gap filled,charting predictable,appears something coming and float locked up @zero/restricted borrow,436% fee
👍️0
81vette 81vette 2 년 전
zero borrow,no shares to short,squeeze em babe!!!!
👍️0
81vette 81vette 2 년 전
Shares Outstanding 5.74M,Shares Float 3.77M,Institutional Ownership 6.96%,Insider Ownership 34.42%,Short Float 6.25%, 235,322 shares short
👍️0
MegaDeath MegaDeath 2 년 전
LIPO, Nice day here so far. Thanks for the heads up Hanibal.
👍️0
makinezmoney makinezmoney 2 년 전
$LIPO: Niceeeeeeeeee bounce here....... now 3.80


Came off the bottom.................. nice mercy bounce there from $3 at the open

GO $LIPO
👍️0

최근 히스토리

Delayed Upgrade Clock